Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-46,000
Closed -$2.74M 378
2025
Q1
$2.74M Buy
+46,000
New +$2.92M 0.06% 99
2024
Q4
Sell
-85,820
Closed -$6.18M 435
2024
Q3
$6.18M Buy
+85,820
New +$5.99M 0.15% 74
2023
Q4
Sell
-70,150
Closed -$6.92M 518
2023
Q3
$6.92M Buy
70,150
+27,500
+64% +$2.84M 0.12% 83
2023
Q2
$4.35M Buy
+42,650
New +$4.22M 0.09% 139
2023
Q1
Sell
-7,163
Closed -$667K 628
2022
Q4
$667K Sell
7,163
-72,115
-91% -$6.85M 0.01% 599
2022
Q3
$6.2M Buy
+79,278
New +$7.61M 0.07% 178
2020
Q3
Sell
-47,500
Closed -$3.7M 327
2020
Q2
$3.7M Buy
+47,500
New +$3.27M 0.08% 179
2015
Q2
Sell
-6,046
Closed -$482K 777
2015
Q1
$482K Buy
+6,046
New +$454K ﹤0.01% 673

Other funds holding APTV

UBS O'Connor's APTV Position: Q2 2025 in Review

UBS O'Connor sold out of Aptiv (APTV) in Q2 2025, closing a stake of 46,000 shares — an estimated $2.74M sold.

UBS O'Connor first reported a position in APTV in Q1 2015 and held it in 8 quarters. The position peaked at $6.92M in Q3 2023. 635 funds tracked by Wall St. Rank hold APTV as of Q2 2025.

  • UBS O'Connor reported no remaining Aptiv position as of Q2 2025 after selling out during the quarter.
  • UBS O'Connor sold 46,000 Aptiv shares in Q2 2025, an estimated $2.74M.
  • UBS O'Connor first reported a position in Aptiv in Q1 2015 and held it in 8 quarters.
  • UBS O'Connor's Aptiv position peaked at $6.92M in Q3 2023.
  • 635 funds tracked by Wall St. Rank held Aptiv as of Q2 2025.

Based on UBS O'Connor's 13F filing for Q2 2025, filed 14 Aug 2025.